Angiotensin Receptor Blockers in Aortic Stenosis
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 144 participants.
Also called NCT04913870
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 144 participants
- Sponsor
- Registry
-
NCT04913870
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada, Denmark
- Registry status
- Recruiting
Technical summary
Registry record NCT04913870. Randomized; quadruple masking; primary purpose treatment. Start 2020-02-01 (actual); primary completion 2027-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Angiotensin Receptor Blockers in Aortic Stenosis
- Acronym
- ARBAS
- Condition
- Aortic Stenosis
- Condition
- Aortic Valve Stenosis
- Intervention (Drug)
- Angiotensin Receptor Blockers
- Intervention (Other)
- Placebo
- Lead sponsor
- Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
- Collaborator
- Odense University Hospital
Record details
- Record id
cardio:ct-nct04913870- Content hash
82b3e7fe735bad4820a2d028d9f4eca83a3b0bc7dd0038b1c5d3a9b0e3b7c6ae